FDA issued a Warning Letter to Anicare Pharmaceuticals Pvt Ltd. on 2/28/2019 for a later inspection.
483 Anicare Pharmaceuticals Jul 2016

483 Anicare Pharmaceuticals Jul 2016

$119 - Not in Stock

FDA investigators audited the Anicare Pharmaceuticals - Navi Mumbai, India facility and issued inspectional observations (via FDA 483) on 14 Jul 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 14 Jul 2016
  • Location: Navi Mumbai, India
  • FEI: 3007450508

Pre-Order Not Available